Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Treating dyslipidemia in the elderly.

Khan Pohlel1, Parker Grow, Tarek Helmy

  • 1Emory University School of Medicine, Atlanta, Georgia 30303, USA.

Current Opinion in Lipidology
|January 13, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Balloon-Assisted Translocation of the Mitral Anterior Leaflet to Prevent Outflow Tract Obstruction During TMVR: The BATMAN Registry.

JACC. Cardiovascular interventions·2026
Same author

Correction: Heart Disease in Older Women: Unique Challenges in Diagnosis and Management.

Current cardiology reports·2026
Same author

Heart Disease in Older Women: Unique Challenges in Diagnosis and Management.

Current cardiology reports·2026
Same author

Acute Plaque Rupture and an ST-Segment Elevation Myocardial Infarction in a Young Competitive Athlete.

JACC. Case reports·2026
Same author

Sex-Related Differences in Outcomes of Left Atrial Appendage Occlusion Device Placement.

Pacing and clinical electrophysiology : PACE·2026
Same author

Impact of Obesity in Hospitalized Patients Undergoing Catheter Ablation for Atrial Fibrillation.

Pacing and clinical electrophysiology : PACE·2025

Lipid-lowering therapy is safe and effective for managing chronic conditions in the growing elderly population. Recent data support its use in older adults to prevent disease progression and reduce mortality.

Area of Science:

  • Gerontology
  • Cardiovascular Medicine
  • Pharmacology

Background:

  • The elderly population (65+ years) is rapidly expanding in the US.
  • Chronic diseases like cardiovascular disease, metabolic syndrome, and diabetes are prevalent in this demographic.
  • Management strategies for dyslipidemia require updated consideration due to recent clinical trial data.

Purpose of the Study:

  • To review current lipid management guidelines for the elderly.
  • To discuss clinical trial evidence supporting lipid-lowering therapy in older adults.
  • To examine the benefits of lipid-lowering interventions for common chronic conditions in the elderly.

Main Methods:

  • Review of recent clinical trial data.
  • Analysis of guidelines for lipid management in the elderly.

Related Experiment Videos

  • Examination of evidence for lipid-lowering therapy efficacy and safety in older populations.

    • Main Results:

    • Clinical trials since 2001 support lipid-lowering therapy in the elderly.
    • Therapy is generally safe and effective in managing chronic diseases common in this age group.
    • Lipid-lowering interventions can help manage conditions such as cardiovascular disease, metabolic syndrome, and diabetes.

    Conclusions:

    • The growing elderly population faces increased incidence of chronic diseases.
    • Lipid-lowering therapy is a key strategy to prevent or delay disease progression.
    • This therapy reduces associated mortality and morbidity in older adults.